|
Market Cap (24-Jun) $24,941,990 (1,259th) |
Close (30-Jun) $0.080 |
Volume (30-Jun) 244,049 |
Shortsold (15-Jan) 38,875 (0.01%) (540th) |
|
52w High $0.260 |
52w Low $0.059 |
P/E - |
EPS -0.02 |
NSB released this announcement to the ASX on 29 April 2022, 8:00. The announcement is marked as price sensitive, and is 8 page(s) in length and 284.15kb in size.
You can view all announcements from NSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, NSB was 0.012% short sold according to ASIC data. It was ranked the 639th most shorted stock on the ASX. It is now ranked as the 540th most shorted stock on the ASX with 0.012% of total shares short sold as of the latest reported data (15 January 2026).
| Other Recent Announcements from NSB | |
|---|---|
| Change of Director's Interest Notice - Rennie | 7 June 2023, 8:22 |
| Change of Director's Interest Notice - Uvarov | 25 May 2023, 15:30 |
| Change of Director's Interest Notice - Rennie | 25 May 2023, 15:07 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 29 April 2022, 8:00 |
| Positive safety result supports advance to clinical trials | 13 April 2022, 10:27 |
| NSB Enhances Management Team | 1 April 2022, 10:23 |
| Company Presentation | 24 March 2022, 17:42 |
You must be logged in to post a reply.
NeuroScientific Biopharmaceuticals 